Publications database

The use of substitution drugs for the treatment of opioid dependence represents a key evidence-based response to heroin problems in Europe. However, the diversion of these medicines from their intended use in...

Psychosocial interventions are structured psychological or social interventions used to address substance-related problems. They can be used at different stages of drug treatment to identify the problem, treat it and assist with...

A journalists’ guide to upcoming events and products from the EU drugs agency in Lisbon, May 2016.

This report explores the recent resurgence in use of MDMA in Europe and increased availability of high-strength MDMA tablets, crystals and powders. It notes that the picture is not uniform across European...

April–June 2016​ In this issue: 2016 EU Drug Markets Report | Monitoring illicit drugs in wastewater | UNGASS 2016 | Strengthening early warning on new synthetic opioids | New EMCDDA products and...

This poster was produced for the event ISSDP Regional Conference / Cannabis science and policy summit held in New York, 17-18 April 2016.

The EU Drug Markets Report 2016 is the second comprehensive overview of illicit drug markets in the European Union by the EMCDDA and Europol. The analysis provided in this report spans numerous...

This publication provides a strategic overview of the key findings of the 2016 EU Drug Markets Report: In-depth Analysis. The report brings together our knowledge and understanding of the operation and structure...

This report includes estimates of the total size of the retail drug market in the European Union (EU) in 2013 for cannabis, heroin, cocaine, amphetamines and ecstasy. October 2018 : An error...

Assessing illicit drugs in wastewater: advances in wastewater-based drug epidemiology reviews a new approach to estimating drug use in populations, based on the detection and quantification of drugs and their metabolic products...